Want to join the conversation?
Dara Mohsenian of Morgan Stanley asks about $STZ's cash flow priorities. CFO Rob Sands replied that the company's capital priorities have not changed at all. He added that the company increased its annual dividend at the end of 2015 and has made some stock repurchases, and this remains a key priority for $STZ.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?